Active	Status	Sponsor type	Region	Phase	Filter
5 Active 2 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Diaz, Luis
NCT03832569: Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors	Active, not recruiting	1	17	US	Pembrolizumab	Memorial Sloan Kettering Cancer Center, Merck Sharp & Dohme LLC	Solid Tumors, Identified by NGS, PCR or IHC	02/25	02/25
TARGET-HCC, NCT02954094: A Longitudinal Observational Study of the Natural History and Management of Patients With HCC	Recruiting	N/A	10000	Europe, US		Target PharmaSolutions, Inc.	Hepatocellular Cancer	10/25	10/25
Vasquez, Cesar
No trials found
Pimentel, Federico Suero
No trials found